Search

Proposed changes to voluntary federal guidelines for prescribing opioid painkillers emphasize that doctors should first try other treatments for acute, subacute, and chronic pain. The non-opioid treatment options suggested by the U.S. Centers for Disease Control and Prevention include prescription medications like gabapentin and over-the-counter painkillers like ibuprofen (Advil, Motrin), as well as physical therapy, massage, and...

Vaso-occlusive events in sickle cell disease are managed with opioids, but there are several side effects. Ketamine is proposed as an adjunctive therapy that may reduce the need for high-dose opioids. Sickle cell disease causes vaso-occlusive pain episodes, typically managed with opioids and NSAIDs Ketamine might be an effective therapy to add to VOE management...

Diagnostic performance comparable for two test sets from the Personal Performance in Mammographic Screening scheme. Diagnostic performance of an artificial intelligence (AI) algorithm is comparable to human reader performance for interpreting mammographic screening, according to a study published online Sept. 5 in Radiology. Yan Chen, Ph.D., from the University of Nottingham in the United Kingdom,...

Detecting melanoma early in patients is crucial for ensuring positive outcomes. A cross-sectional audit study explains the importance of increasing healthcare access and educating primary care physicians on diagnostic techniques. Melanoma is one of the most common cancers with a generally good prognosis if caught early. However, the late detection of melanoma could lead to...

Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 12 to 16, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice. Reinfection With SARS-CoV-2 Described...

What can clinicians do to continue treating patients with Hodgkin’s lymphoma (HL) during a widespread shortage of the drugs typically used to do so? This study, published in Blood, reviewed this predicament experienced by hematologists/oncologists in Mexico from mid-2019 to mid-2021. The study will be presented at the 2021 ASH Annual Meeting & Exposition.  During the drug...

Staying healthy is an ideal goal for everyone. However, the steps you need to take to stay healthy vary from person to person. For women in minority groups, the steps need to address the specific issues they deal with.  This article will explore some of the best ways women in minority groups can stay healthy....

Recruitment and enrollment of diverse participants representative of the general population are essential to gain meaningful insight into novel drug therapies. Oncological studies have been previously noted as lacking gender balance, which can result in skewed clinical trial results. This study, published in the Journal of Clinical Oncology, focuses on drug registration trials in particular,...

Recent advancements have significantly transformed the treatment landscape for relapsed or refractory classic Hodgkin lymphoma. The emergence of innovative therapies promises better outcomes and sets the path for personalized treatment strategies. Classic Hodgkin lymphoma cure rates have improved with chemotherapy, yet 10–30% of patients experience relapse or refractory disease. The last decade has witnessed the...